| 书目名称 | Cardio-Oncology |
| 副标题 | Management of Toxici |
| 编辑 | Antonio Russo,Nicola Maurea,Antonio Giordano |
| 视频video | |
| 概述 | Provides a complete and updated state-of-art review.Written by experts in the field.Addresses the future perspectives in the cardio-immunology field |
| 丛书名称 | Current Clinical Pathology |
| 图书封面 |  |
| 描述 | The development of immunotherapy in oncology field has revolutionized the prognosis of many types of cancer. The immune checkpoint inhibitors target receptors whose inhibition increases the activity of immune system cells against tumor cells. In recent years, new immunotherapies have been studied and approved in a growing number of tumors including melanoma, non-small cell lung cancer (NSCLC), and renal cell cancer (RCC). This volume provides a complete and updated state-of-art review regarding the management of cardiovascular toxicities from new immunotherapies. The manuscript is divided into different sections starting from the relationship between cancer and immune system to let the reader understand the new molecular concepts under immunotherapy development. Subsequent chapters describe specifically the immunotherapy options in solid tumor treatment and the main features of the immuno-related cardiovascular complications. This volume is written by experts in the oncological and cardiovascular fields and aims to provide to clinicians who approach current cancer patients a useful tool to move through the paths of modern cardio-oncology. An important section would afford the most |
| 出版日期 | Book 2022 |
| 关键词 | Immunotherapy; cardiac toxicity; Physiopathology; Biomarkers; Immunology and cancer |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-030-97744-3 |
| isbn_softcover | 978-3-030-97746-7 |
| isbn_ebook | 978-3-030-97744-3Series ISSN 2197-781X Series E-ISSN 2197-7828 |
| issn_series | 2197-781X |
| copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
发表于 2025-3-21 16:41:49
